Selected article for: "death rate and low death rate"

Author: Ashish Goyal; E. Fabian Cardozo-Ojeda; Joshua T Schiffer
Title: Potency and timing of antiviral therapy as determinants of duration of SARS CoV-2 shedding and intensity of inflammatory response
  • Document date: 2020_4_14
  • ID: d7stppv5_110
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . Fig S7. Treatment projections of cytolytic immunotherapy assuming different potency and timing of treatment. Each set of simulations is performed under assumptions of high, medium and low potency based on multiplicative effect on infected cell death rate. Treatment initiation is at timepoints generally consistent with a. hospitalization (day 10 after first positive samp.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . Fig S7. Treatment projections of cytolytic immunotherapy assuming different potency and timing of treatment. Each set of simulations is performed under assumptions of high, medium and low potency based on multiplicative effect on infected cell death rate. Treatment initiation is at timepoints generally consistent with a. hospitalization (day 10 after first positive sample), b. first symptoms (day 5 after first positive sample), c. pre-symptomatic post-peak phase (day 2 after first positive sample) and d. pre-symptomatic pre-peak phase (day 0). Overall, early potent treatment limits duration of infection.

    Search related documents:
    Co phrase search for related documents
    • positive sample 10 day hospitalization and post peak phase: 1, 2, 3, 4, 5
    • positive sample 10 day hospitalization and pre peak phase: 1, 2, 3, 4, 5
    • positive sample 10 day hospitalization and pre symptomatic pre peak phase: 1, 2, 3, 4
    • positive sample 10 day hospitalization and timing different potency: 1
    • positive sample 10 day hospitalization and treatment initiation: 1, 2, 3, 4, 5
    • positive sample 10 day hospitalization and treatment timing different potency: 1
    • post peak phase and pre peak phase: 1, 2, 3, 4, 5, 6, 7, 8
    • post peak phase and pre symptomatic pre peak phase: 1, 2, 3, 4, 5
    • post peak phase and timing different potency: 1
    • post peak phase and treatment initiation: 1, 2, 3, 4, 5
    • post peak phase and treatment timing different potency: 1
    • pre peak phase and timing different potency: 1
    • pre peak phase and treatment initiation: 1, 2, 3, 4, 5
    • pre peak phase and treatment timing different potency: 1
    • pre symptomatic pre peak phase and timing different potency: 1
    • pre symptomatic pre peak phase and treatment initiation: 1, 2, 3, 4
    • pre symptomatic pre peak phase and treatment timing different potency: 1
    • timing different potency and treatment initiation: 1
    • timing different potency and treatment timing different potency: 1, 2